Chenyu Lin

机构：Duke University, Guangzhou Sport University, Duke Medical Center, Duke University Health System · ORCID：0000-0002-4542-4232

发表论文 124 篇 · 总被引 944 次 · h-index 15

代表论文

• Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults (2025 · Blood Cancer Journal · 被引 13)
• Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias (2026 · Blood Advances · 被引 4)
• CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia (2025 · Blood Advances · 被引 3)
• Pre- or post-CAR-T allogeneic hematopoietic cell transplant provides relapse-free survival benefit for R/R Philadelphia negative B-cell acute lymphoblastic leukemia (B-ALL) successfully treated with brexucabtagene autoleucel in the real world (2025 · Blood · 被引 2)
• Real-world toxicity of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (2025 · Blood Immunology & Cellular Therapy · 被引 1)
• Choice of hypomethylating agent for newly diagnosed TP53-mutant Acute Myeloid Leukemia: A command registry study (2025 · Blood · 被引 1)